HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

OTC labeling reg packaging changes would cost industry over $1 bil. -- NDMA.

This article was originally published in The Rose Sheet

Executive Summary

PACKAGING CHANGES WOULD EXCEED $1 BIL. UNDER OTC LABELING REGS, NDMA asserts in comments submitted to FDA Oct. 6 on the proposed labeling requirements for OTC drugs. Citing the "substantive" labeling requirements proposed, the Nonprescription Drug Manufacturers Association says in addition to labeling changes, physical alterations to the packaging of a large number of products would be necessary to comply with the reg. Based on a survey of its members, NDMA estimates the total cost to industry of changing packaging to accommodate the reg would total $1.27 bil.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS004738

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel